Estrogenic modulation of inflammation-related genes in male rats following volume overload

Physiological Genomics

Volumn 44, Issue 6, 2012, Pages 362-373

  Mclarty, Jennifer L ^a   Meléndez, Giselle C ^a   Levick, Scott P ^a   Bennett, Shanté ^a   Sabo Attwood, Tara ^b   Brower, Gregory L ^a   Janicki, Joseph S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

1 integrin; Aortocaval fistula; Prostaglandin; Receptors; Tumor necrosis factor

Indexed keywords

BETA1 INTEGRIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESTROGEN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEART PROTECTION; HEART VOLUME; INFLAMMATION; MALE; MODULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD29; AORTA, ABDOMINAL; BLOTTING, WESTERN; CARDIAC VOLUME; CARDIOTONIC AGENTS; ESTROGENS; FISTULA; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

ANIMALIA; FISTULA; RATTUS;

EID: 84859447982     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00146.2011     Document Type: Article

References (43)

1. An J, Ribeiro RCJ, Webb P, Gustafsson J, Kushner PJ, Baxter JD, Leitman DC. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 96: 15161-15166, 1999.
2. Bozkurt B, Torre-Amione G, Smith-Warren M, Whitmore J, Soran OZ, Feldman AM, Mann DL. Results of targeted anti-tumor necrosis factor therapy with etanercept (Enbrel) in patients with advanced heart failure. Circulation 103: 1044-1047, 2001.
3. Bozkurt B, Kribbs SB, Clubb FJ, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologi-cally relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391, 1998.
4. Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol Heart Circ Physiol 271: H2071-H2078, 1996.
5. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 283: H518-H525, 2002.
6. Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP, Janicki JS. The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 30: 604-610, 2006.
7. Brower GL, Gardner JD, Janicki JS. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 251: 89-95, 2003.
8. Brower GL, Janicki JS. Contribution of ventricular remodeling to patho-genesis of heart failure in rats. Am J Physiol Heart Circ Physiol 280: H674-H683, 2001.
9. Brower GL, Janicki JS. Pharmacologic inhibition of mast cell degranu- lation prevents left ventricular remodeling induced by chronic volume overload in rats. J Cardiac Failure 11: 548-556, 2005.
10. Du Y. Gender differences in cardiomyocyte remodeling and adhesion in response to chronic elevations in myocardial stress (PhD dissertation). Columbia, SC: University of South Carolina, 2010, AAT 3402767.
11. Du Y, Plante E, Janicki JS, Brower GL. Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload. Am J Pathol 177: 1155-1163, 2010.
12. Ferguson HE, Kulkarni A, Lehmann GM, Garcia-Bates TM, Thatcher TH, Huxlin KR, Phipps RP, Sime PJ. Electrophilic peroxi-some proliferator-activated receptor-gamma ligands have potent antifi-brotic effects in human lung fibroblasts. Am J Respir Cell Mol Biol 41: 722-730, 2009.
13. Francois H, Athirakul K, Howell D, Dash R, Mao L, Kim HS, Rockman HA, FitzGerald GA, Koller BH, Coffman TM. Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab 2: 201-207, 2005.
14. Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPAR-gamma: possible relevance to human fibrotic disorders. Proc Natl Acad Sci USA 99: 15072-15077, 2002.
15. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875, 2001.
16. Gardner JD, Brower GL, Janicki JS. Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats. J Appl Physiol 99: 1378-1383, 2005.
17. Gardner JD, Brower GL, Janicki JS. Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 8: 101-107, 2002.
18. Gardner JD, Brower GL, Voloshenyuk TG, Janicki JS. Cardioprotec-tion in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circ Physiol 294: H198-H204, 2008.
19. Gardner JD, Murray DB, Voloshenyuk TG, Brower GL, Bradley JM, Janicki JS. Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am J Physiol Heart Circ Physiol 298: H497-H504, 2010.
20. Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, Sortino M, Crimi N, Caputi AP, Thiemermann C, Vancheri C. Effect of rosiglitazone and 15-deoxy-delta 12,14-prostaglan-din J2 on bleomycin-induced lung injury. Eur Respir J 25: 225-234, 2005.
21. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure. Circulation 119: 1386-1397, 2009.
22. Janicki JS, Brower GL, Gardner JD, Forman MF, Stewart JA, Murray DB, Chancey AL. Cardiac mast cell regulation of matrix met-alloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69: 657-665, 2006.
23. Jobe LJ, Melendez GC, Levick SP, Du Y, Brower GL, Janicki JS. TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol 297: H1462-H1468, 2009.
24. Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM. Sex-related survival differences in murine cardiomyopathy are associated with differences n TNF-receptor expression. J Clin Invest 106: 589-597, 2000.
25. Kim SY, Weiss J, Tong M, Laronda MM, Lee EJ, Jameson JL. Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alpha. Endocrinology 150: 5085-5093, 2009.
26. Levick SP, Gardner JD, Holland M, Hauer-Jensen M, Janicki JS, Brower GL. Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats. J Mol Cell Cardiol 45: 56-61, 2008.
27. Levick SP, Loch DC, Taylor SM, Janicki JS. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 178: 641-646, 2007.
28. Linzbach AJ. Hypertrophy, hyperplasia, and structural dilatation of the human heart. Adv Cardiol 18: 1-14, 1976.
29. ^^Ct method. Methods 25: 402-408, 2001.
30. Murray DB, Gardner JD, Brower GL, Janicki JS. Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287: H2295-H2299, 2004.
31. Murray DB, Gardner JD, Brower GL, Janicki JS. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats. Am J Physiol Heart Circ Physiol 294: H1251-H1257, 2008.
32. Murray D, Gardner JD, Brower GL, Janicki JS. Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol 287: H2295-H2299, 2004.
33. Nijmeijer R, Lagrand WK, Baidoshvili A, Lubbers YTP, Hermens WT, Meijer CJLM, Visser CA, Hack CE, Niessen HWM. Secretory type II phospholipase A2 binds to ischemic myocardium during myocar-dial infarction in humans. Cardiovasc Res 53: 138-146, 2002.
34. Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res 67: 23-34, 1990.
35. Pechenino AS, Li Lin Mbai FN, Lee AR, He XM, Stallone JN, Knowlton AA. Impact of aging vs estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics 43: 1065-1073, 2011.
36. Srivastava S, Weitzmann M, Cenci S, Ross F, Adler S, Pacifici R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104: 503-513, 1999.
37. Stewart J, Cashatt DO, Borck AC, Brown JE, Carver WE. 17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. J Mol Cell Cardiol 41: 97-107, 2006.
38. Su EJ, Lin ZH, Zeine R, Yin P, Reierstad S, Innes JE, Bulun SE. Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. Am J Obstet Gynecol 200: 427, 2009.
39. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA 104: 6013-6018, 2007.
40. Terracio L, Rubin K, Gullberg D, Balog E, Carver W, Jyring R, Borg TK. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 68: 734-744, 1991.
41. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human hearts. Circulation 93: 704-711, 1996.
42. Wilson CG, Stone JW, Fowlkes V, Morales MO, Murphy CJ, Baxter SC, Goldsmith EC. Age-dependent expression of collagen receptors and deformation of type I collagen substrates by rat cardiac fibroblasts. Microsc Microanal 17: 555-562, 2011.
43. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 69: 836-844, 2006.